Fares Ejeh-Al - Publications

Emerging precision medicine in multiple myeloma: clinical and preclinical landscape of T cell, natural killer cell, and macrophages engaging multi-specific antibodies.

Journal: Frontiers in immunology

Published: March 03, 2026

EphA2 regulates vascular permeability and prostate cancer metastasis via modulation of cell junction protein phosphorylation.

Journal: Oncogene

Published: August 02, 2023

Cancer Incidence and Mortality Estimates in Arab Countries in 2018: A GLOBOCAN Data Analysis.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: May 07, 2023

Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer.

Journal: NPJ breast cancer

Published: October 09, 2021

Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications.

Journal: Nature communications

Published: December 18, 2020

G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 02, 2020

Differential gene expression of tumor-infiltrating CD8+ T cells in advanced versus early-stage colorectal cancer and identification of a gene signature of poor prognosis.

Journal: Journal for immunotherapy of cancer

Published: August 17, 2020

Clinicopathologic significance of nuclear HER4 and phospho-YAP(S127) in human breast cancers and matching brain metastases.

Journal: Therapeutic advances in medical oncology

Published: March 27, 2020

G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome.

Journal: Theranostics

Published: October 23, 2019

Proteomic Analysis of the Breast Cancer Brain Metastasis Microenvironment.

Journal: International journal of molecular sciences

Published: March 29, 2019

Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer.

Journal: JCI insight

Published: March 05, 2019

EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma.

Journal: Cancers

Published: November 13, 2018